
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Torbjörn Tomson, MD, PhD - professor in neurology, Karolinska Institutet - discusses how health care providers can work with patients to prevent sudden unexpected death in epilepsy (SUDEP).
Torbjörn Tomson, MD, PhD - professor in neurology, Karolinska Institutet - discusses how health care providers can work with patients to prevent sudden unexpected death in epilepsy (SUDEP).






